Clinical characteristics and outcomes in patients with Anti-MDA5 positive interstitial lung disease: A case series from a lung transplant center

This case series underscores the heterogeneous trajectory of <i>anti</i>-MDA5+DM-ILD and highlights the importance of timely diagnosis, aggressive immunosuppressive treatment, and early transplant evaluation in severe cases. Serial monitoring of <i>anti</i>-MDA5 antibody titers and lung function testing may help guide therapeutic decisions and prognostication.